Famed New York Philanthropist Commits $7 Million to Advanced Prostate Cancer Research
Generous Commitments from Stewart Rahr to Support PCF-Stand Up To Cancer Dream Team and Research Programs Sponsored by PCF
November 19, 2012 -- New York’s philanthropic billionaire Stewart Rahr, this week gave research focused on curing prostate cancer a huge boost, committing $7 million to support the cause. Of the $7 million, $5 million of the donation will go to support a recently announced PCF-Stand Up to Cancer Dream Team with the remainder earmarked to support various Prostate Cancer Foundation (PCF) research awards, including funding to PCF Young Investigators.
The Dream Team supported by Rahr’s donation is a seven institution, international project that will be led by Drs. Arul Chinnaiyan at the University of Michigan and Charles Sawyers at Memorial Sloan-Kettering Cancer Center in New York. This unique research program will focus on developing protocols, based on genomics and informatics, pathology, bioethics, clinical genetics and clinical oncology, that will deliver precision therapies to patients within five weeks of a positive biopsy. Five other institutions working as part of this Dream Team include Broad Institute (Boston), Dana Farber Cancer Institute (Boston), Fred Hutchinson Cancer Research Center (Seattle), Institute of Cancer Research/The Royal Marsden Hospital (London) and Weill Cornell Medical College (New York).
“Stewart Rahr has been a huge supporter of the work of the Prostate Cancer Foundation and we are extremely grateful for his continued generosity,” said Jonathan W. Simons, MD, president and CEO of PCF. “His philanthropic spirit will inevitably change the treatment landscape for prostate cancer and reduce death and suffering as a result of this disease. Millions of men and their families will benefit from Stewart’s humanity.”
“This is a vitally important cause and I am honored to be able to help the Prostate Cancer Foundation with all of their work,” said Stewart Rahr. “I am confident that this unique program will have a positive impact.”
Stewart Rahr is listed as #298 on the Forbes 400 according to Forbes Magazine.
About the Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization funding and accelerating research. Founded in 1993, PCF has generated more than $475 million and provided funding to over 1,600 research projects at nearly 200 institutions in 15 countries around the world. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds supporting transformational cancer research. Our efforts have helped produce a 20-fold increase in government funding for prostate cancer. More information about PCF can be found at pcf.org.